In-Woo Chang
Plus aucun poste en cours
Fortune : 287 525 $ au 31/03/2024
Profil
In-Woo Chang served as the Chief Executive Officer & Director at Alvogen Korea Co., Ltd.
and as an Independent Director at Hankook AtlasBX Co., Ltd.
He received his undergraduate degree from Harvard University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/10/2023 | 100 410 ( 0,29% ) | 287 525 $ | 31/03/2024 |
Anciens postes connus de In-Woo Chang
| Sociétés | Poste | Fin |
|---|---|---|
| HANKOOK ATLASBX CO.,LTD. | Director/Board Member | - |
| KUNWHA PHARMACEUTICAL CO., LTD. | Chief Executive Officer | - |
Formation de In-Woo Chang
| Harvard University | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Alvogen Korea Co., Ltd.
 Alvogen Korea Co., Ltd. Pharmaceuticals: MajorHealth Technology Alvogen Korea Co., Ltd. engages in the manufacture of pharmaceutical products. It offers products for the therapeutic areas of endocrine system, urinary system, neuropsychiatry system, anti-inflammatory, antipyretic, analgesic, gastrointestinal system, cardiovascular system, dermatology, hepatitis, antibiotics, respiratory system, hormones etc. It provides pharmaceutical products in various dosage forms, including tablets, capsules, granules, powders, ampoules, vials and intravenous (IV) solutions. The company was founded on January 7, 1958 and is headquartered in Seoul, South Korea. | Health Technology |
HANKOOK ATLASBX Co., Ltd.
 HANKOOK ATLASBX Co., Ltd. Electrical ProductsProducer Manufacturing HANKOOK ATLASBX Co., Ltd. engages in the manufacture and distribution of batteries. Its products include batteries for automobiles and industries. The company was founded on February 18, 1944 and is headquartered in Daejeon, South Korea. | Producer Manufacturing |
